Functionally, increasing global m6A levels dramatically inhibits human breast cell growth and metastasis, suppressing tumor progression, via overexpression of METTL14 and/or knockdown of the expression of the easer ALKBH5 (77). Here, METTL14 is linked to neoplasm.